These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23441583)

  • 21. A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs.
    Yanni JM; Sharif NA; Gamache DA; Miller ST; Weimer LK; Spellman JM
    Acta Ophthalmol Scand Suppl; 1999; (228):33-7. PubMed ID: 10337430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of mast cell-dependent conversion of cultured macrophages into foam cells with antiallergic drugs.
    Ma H; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):E134-42. PubMed ID: 11116078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research.
    Rosenwasser LJ; O'Brien T; Weyne J
    Curr Med Res Opin; 2005 Sep; 21(9):1377-87. PubMed ID: 16197656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast cell stabilisers.
    Zhang T; Finn DF; Barlow JW; Walsh JJ
    Eur J Pharmacol; 2016 May; 778():158-68. PubMed ID: 26130122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model.
    Shin TY; Kim SH; Suk K; Ha JH; Kim I; Lee MG; Jun CD; Kim SY; Lim JP; Eun JS; Shin HY; Kim HM
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):255-62. PubMed ID: 15936049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the mast cell in allergic bronchospasm.
    Befus D
    Can J Physiol Pharmacol; 1987 Mar; 65(3):435-41. PubMed ID: 3555749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of allergic responses by mitochondrial STAT3 inhibitors.
    Erlich TH; Sharkia I; Landolina N; Assayag M; Goldberger O; Berkman N; Levi-Schaffer F; Razin E
    Allergy; 2018 Nov; 73(11):2160-2171. PubMed ID: 29683527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A molecular understanding of mast cell activation and the promise of anti-allergic therapeutics.
    Kovarova M; Rivera J
    Curr Med Chem; 2004 Aug; 11(15):2083-91. PubMed ID: 15279568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular targets on mast cells and basophils for novel therapies.
    Harvima IT; Levi-Schaffer F; Draber P; Friedman S; Polakovicova I; Gibbs BF; Blank U; Nilsson G; Maurer M
    J Allergy Clin Immunol; 2014 Sep; 134(3):530-44. PubMed ID: 24767877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis.
    Tan JW; Israf DA; Harith HH; Md Hashim NF; Ng CH; Shaari K; Tham CL
    Toxicol Appl Pharmacol; 2017 Mar; 319():47-58. PubMed ID: 28167223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morus bombycis extract suppresses mast cell activation and IgE-mediated allergic reaction in mice.
    Kim JD; Kim DK; Kim HS; Kim AR; Kim B; Her E; Park KH; Kim HS; Kim YM; Choi WS
    J Ethnopharmacol; 2013 Mar; 146(1):287-93. PubMed ID: 23313390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans.
    Weng Z; Zhang B; Asadi S; Sismanopoulos N; Butcher A; Fu X; Katsarou-Katsari A; Antoniou C; Theoharides TC
    PLoS One; 2012; 7(3):e33805. PubMed ID: 22470478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular allergy and mast cell stabilizers.
    Allansmith MR; Ross RN
    Surv Ophthalmol; 1986; 30(4):229-44. PubMed ID: 3082025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action of Dracocephalum argunense on mast cell-mediated allergy model.
    Kim SH; Kim SH; Kim SH; Moon JY; Park WH; Kim CH; Shin TY
    Biol Pharm Bull; 2006 Mar; 29(3):494-8. PubMed ID: 16508152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1.
    Yazid S; Sinniah A; Solito E; Calder V; Flower RJ
    PLoS One; 2013; 8(3):e58963. PubMed ID: 23527056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk.
    Lee JH; Kim JW; Ko NY; Mun SH; Her E; Kim BK; Han JW; Lee HY; Beaven MA; Kim YM; Choi WS
    J Allergy Clin Immunol; 2008 May; 121(5):1225-31. PubMed ID: 18394691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today.
    Caslin HL; Kiwanuka KN; Haque TT; Taruselli MT; MacKnight HP; Paranjape A; Ryan JJ
    Front Immunol; 2018; 9():868. PubMed ID: 29755466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-allergic properties of curine, a bisbenzylisoquinoline alkaloid.
    Ribeiro-Filho J; Piuvezam MR; Bozza PT
    Molecules; 2015 Mar; 20(3):4695-707. PubMed ID: 25781071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.